2013 Q4 Form 10-Q Financial Statement
#000110465913082619 Filed on November 08, 2013
Income Statement
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q4 |
|---|---|---|---|
| Revenue | $620.0K | $980.0K | $3.647M |
| YoY Change | -83.0% | -68.52% | 49.9% |
| Cost Of Revenue | $0.00 | $3.550M | |
| YoY Change | -100.0% | 50.42% | |
| Gross Profit | $980.0K | $100.0K | |
| YoY Change | 790.91% | 25.0% | |
| Gross Profit Margin | 100.0% | 2.74% | |
| Selling, General & Admin | $4.680M | $3.580M | $2.650M |
| YoY Change | 76.6% | 26.06% | 15.72% |
| % of Gross Profit | 365.31% | 2650.0% | |
| Research & Development | $17.80M | $20.42M | $13.75M |
| YoY Change | 29.45% | 73.48% | 40.02% |
| % of Gross Profit | 2083.37% | 13750.0% | |
| Depreciation & Amortization | $760.0K | $730.0K | $720.0K |
| YoY Change | 5.56% | -5.19% | -14.29% |
| % of Gross Profit | 74.49% | 720.0% | |
| Operating Expenses | $22.73M | $20.42M | $16.65M |
| YoY Change | 36.52% | 73.48% | 33.63% |
| Operating Profit | -$23.27M | -$16.55M | |
| YoY Change | 57.75% | 33.68% | |
| Interest Expense | $50.00K | $13.00K | -$260.0K |
| YoY Change | -119.23% | -96.59% | -25.71% |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$22.06M | -$23.14M | -$16.81M |
| YoY Change | 31.23% | 53.96% | 32.05% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$22.06M | -$23.14M | -$16.81M |
| YoY Change | 31.23% | 53.96% | 32.05% |
| Net Earnings / Revenue | -3558.06% | -2361.22% | -460.93% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$3.982M | -$4.285M | -$4.031M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 81.11M shares | 80.99M shares | 61.98M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $303.0M | $136.6M | $83.96M |
| YoY Change | 260.86% | 75.98% | 57.49% |
| Cash & Equivalents | $169.4M | $14.63M | $24.90M |
| Short-Term Investments | $133.6M | $122.0M | $59.07M |
| Other Short-Term Assets | $1.700M | $2.500M | $1.100M |
| YoY Change | 54.55% | 108.33% | -8.33% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $500.0K | $900.0K | $0.00 |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $305.2M | $139.9M | $85.11M |
| YoY Change | 258.56% | 77.57% | 55.65% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $9.973M | $8.814M | $7.205M |
| YoY Change | 38.42% | 16.49% | -20.76% |
| Goodwill | $8.965M | $8.965M | $8.965M |
| YoY Change | 0.0% | 0.0% | 0.0% |
| Intangibles | $22.82M | $23.07M | $23.83M |
| YoY Change | -4.25% | -4.21% | -4.37% |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $148.0K | $157.0K | $424.0K |
| YoY Change | -65.09% | -61.61% | 28.88% |
| Total Long-Term Assets | $41.91M | $41.01M | $40.43M |
| YoY Change | 3.66% | -0.04% | -6.66% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $305.2M | $139.9M | $85.11M |
| Total Long-Term Assets | $41.91M | $41.01M | $40.43M |
| Total Assets | $347.1M | $181.0M | $125.5M |
| YoY Change | 176.48% | 51.0% | 28.11% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.243M | $1.982M | $745.0K |
| YoY Change | 201.07% | 54.72% | -20.32% |
| Accrued Expenses | $17.18M | $13.81M | $10.96M |
| YoY Change | 56.74% | 69.27% | 56.39% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | $0.00 | $5.600M |
| YoY Change | -100.0% | -100.0% | -8.2% |
| Total Short-Term Liabilities | $20.35M | $16.80M | $17.69M |
| YoY Change | 15.07% | 11.0% | 23.69% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $5.700M |
| YoY Change | -100.0% | -100.0% | -36.67% |
| Other Long-Term Liabilities | $6.950M | $7.415M | $6.336M |
| YoY Change | 9.69% | 16.5% | 6.2% |
| Total Long-Term Liabilities | $6.950M | $7.415M | $6.336M |
| YoY Change | 9.69% | 16.5% | 6.2% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $20.35M | $16.80M | $17.69M |
| Total Long-Term Liabilities | $6.950M | $7.415M | $6.336M |
| Total Liabilities | $27.30M | $24.21M | $29.77M |
| YoY Change | -8.29% | -16.0% | 1.69% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$345.7M | -$323.6M | -$264.1M |
| YoY Change | 30.88% | 30.85% | 28.84% |
| Common Stock | $662.8M | $477.7M | $357.2M |
| YoY Change | 85.58% | 42.35% | 31.76% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $319.8M | $156.7M | $95.77M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $347.1M | $181.0M | $125.5M |
| YoY Change | 176.48% | 51.0% | 28.11% |
Cashflow Statement
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$22.06M | -$23.14M | -$16.81M |
| YoY Change | 31.23% | 53.96% | 32.05% |
| Depreciation, Depletion And Amortization | $760.0K | $730.0K | $720.0K |
| YoY Change | 5.56% | -5.19% | -14.29% |
| Cash From Operating Activities | -$14.96M | -$17.45M | -$13.32M |
| YoY Change | 12.31% | 59.36% | 42.16% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$2.320M | -$980.0K | -$110.0K |
| YoY Change | 2009.09% | 1300.0% | 0.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$11.50M | $6.540M | -$4.430M |
| YoY Change | 159.59% | 7.92% | -154.36% |
| Cash From Investing Activities | -$13.82M | $5.560M | -$4.540M |
| YoY Change | 204.41% | -7.18% | -156.47% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 183.6M | 630.0K | 19.57M |
| YoY Change | 837.92% | -93.42% | 16208.33% |
| NET CHANGE | |||
| Cash From Operating Activities | -14.96M | -17.45M | -13.32M |
| Cash From Investing Activities | -13.82M | 5.560M | -4.540M |
| Cash From Financing Activities | 183.6M | 630.0K | 19.57M |
| Net Change In Cash | 154.8M | -11.26M | 1.710M |
| YoY Change | 8950.88% | -343.72% | -241.32% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$14.96M | -$17.45M | -$13.32M |
| Capital Expenditures | -$2.320M | -$980.0K | -$110.0K |
| Free Cash Flow | -$12.64M | -$16.47M | -$13.21M |
| YoY Change | -4.31% | 51.38% | 42.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q3 | cldx |
Fair Value Assets Amount Transfers Between Measurement Levels
FairValueAssetsAmountTransfersBetweenMeasurementLevels
|
0 | USD |
| CY2013Q3 | cldx |
Fair Value Liabilities Amount Transfers Between Measurement Levels
FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels
|
0 | USD |
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">(1)  Basis of Presentation</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying unaudited condensed consolidated financial statements have been prepared by Celldex Therapeutics, Inc. (the “Company” or “Celldex”) in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and reflect the operations of the Company and its wholly-owned subsidiary. All intercompany transactions have been eliminated in consolidation.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">These interim financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited financial statements for the year ended December 31, 2012, which are included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 8, 2013.  In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary to fairly state the Company’s financial position and results of operations for the interim periods presented.  The year-end consolidated balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any future interim period or the fiscal year ending December 31, 2013.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At September 30, 2013, the Company had cash, cash equivalents and marketable securities of $136.6 million and working capital of $123.2 million. The Company incurred a loss of $59.5 million for the nine months ended September 30, 2013.  Net cash used in operations for the nine months ended September 30, 2013 was $52.7 million. The Company believes that the cash, cash equivalents and marketable securities at September 30, 2013 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">During the next twelve months, the Company may take further steps to raise additional capital to meet its long-term liquidity needs.  These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of technology programs with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company continues to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company’s negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financing may be dilutive to the Company’s stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company’s ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company’s economic potential from products under development.</font></p> <p style="MARGIN: 0in 0in 0pt;"> </p> </div> | ||
| CY2012Q4 | us-gaap |
Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
|
58909000 | USD |
| CY2013Q3 | us-gaap |
Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
|
121862000 | USD |
| CY2012Q4 | cldx |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
164000 | USD |
| CY2013Q3 | cldx |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
117000 | USD |
| CY2013Q3 | us-gaap |
Goodwill
Goodwill
|
8965000 | USD |
| CY2012Q4 | cldx |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
8000 | USD |
| CY2013Q3 | cldx |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
17000 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
59065000 | USD |
| CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
8965000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3763000 | USD |
| CY2013Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
4523000 | USD |
| CY2013Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
23073000 | USD |
| CY2013Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1006000 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
27596000 | USD |
| CY2013Q3 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
27596000 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
23833000 | USD |
| CY2012Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
6724000 | USD |
| CY2013Q3 | us-gaap |
Other Liabilities
OtherLiabilities
|
8421000 | USD |
| CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
6336000 | USD |
| CY2012Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
434000 | USD |
| CY2013Q3 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
404000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
4661000 | USD |
| CY2013Q3 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
4661000 | USD |
| CY2012Q4 | cldx |
Deferred Income From Sale Of Tax Benefits
DeferredIncomeFromSaleOfTaxBenefits
|
1118000 | USD |
| CY2013Q3 | cldx |
Deferred Income From Sale Of Tax Benefits
DeferredIncomeFromSaleOfTaxBenefits
|
1630000 | USD |
| CY2012Q4 | us-gaap |
Loans Payable
LoansPayable
|
472000 | USD |
| CY2013Q3 | us-gaap |
Loans Payable
LoansPayable
|
428000 | USD |
| CY2012Q4 | us-gaap |
Other Sundry Liabilities
OtherSundryLiabilities
|
39000 | USD |
| CY2013Q3 | us-gaap |
Other Sundry Liabilities
OtherSundryLiabilities
|
61000 | USD |
| CY2013Q1 | cldx |
Value Of Tax Benefits Agreed To Be Sold
ValueOfTaxBenefitsAgreedToBeSold
|
800000 | USD |
| CY2012Q1 | cldx |
Value Of Tax Benefits Agreed To Be Sold
ValueOfTaxBenefitsAgreedToBeSold
|
800000 | USD |
| CY2011Q1 | cldx |
Value Of Tax Benefits Agreed To Be Sold
ValueOfTaxBenefitsAgreedToBeSold
|
600000 | USD |
| CY2013Q1 | cldx |
Value At Which Tax Benefits Sold
ValueAtWhichTaxBenefitsSold
|
800000 | USD |
| CY2012Q1 | cldx |
Value At Which Tax Benefits Sold
ValueAtWhichTaxBenefitsSold
|
700000 | USD |
| CY2011Q1 | cldx |
Value At Which Tax Benefits Sold
ValueAtWhichTaxBenefitsSold
|
500000 | USD |
| cldx |
Period For Which Base Of Operations Must Be Maintained
PeriodForWhichBaseOfOperationsMustBeMaintained
|
P5Y | ||
| us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
12075000 | shares | |
| cldx |
Common Stock Exercise Of Full Over Allotment Option To Purchase Additional Shares By Underwriter
CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter
|
1575000 | shares | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
43400000 | USD | |
| us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
13800000 | shares | |
| cldx |
Common Stock Exercise Of Full Over Allotment Option To Purchase Additional Shares By Underwriter
CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter
|
1800000 | shares | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
97000000 | USD | |
| CY2013Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3578000 | USD |
| CY2013Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
254000 | USD |
| CY2013Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
180955000 | USD |
| CY2013Q3 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
136600000 | USD |
| CY2013Q3 | cldx |
Working Capital
WorkingCapital
|
123200000 | USD |
| us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-59000 | USD | |
| CY2013Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
138000 | USD |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-59000 | USD | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-59488000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-52712000 | USD | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6086377 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5360999 | shares | |
| CY2013Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2548000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2745000 | USD |
| CY2013Q3 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
138000 | USD |
| CY2013Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2686000 | USD |
| CY2013Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
7415000 | USD |
| CY2013Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
156745000 | USD |
| CY2013Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2016000 | USD |
| CY2012Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
525000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3400000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1614000 | USD | |
| CY2013Q3 | us-gaap |
Liabilities
Liabilities
|
24210000 | USD |
| CY2013Q3 | us-gaap |
Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
|
3 | item |
| CY2013Q2 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
33000 | |
| cldx |
Operating Leases Term Of Lease
OperatingLeasesTermOfLease
|
P5Y5M | ||
| cldx |
Operating Leases Commencement Period Of Rental Obligations
OperatingLeasesCommencementPeriodOfRentalObligations
|
P5M | ||
| CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
400000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
64359513 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
81108109 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
81108109 | shares |
| CY2012Q3 | cldx |
Revenue From Product Development And Licensing Agreements
RevenueFromProductDevelopmentAndLicensingAgreements
|
28000 | USD |
| CY2012Q3 | cldx |
Revenue From Contracts And Grants
RevenueFromContractsAndGrants
|
79000 | USD |
| CY2012Q3 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
3006000 | USD |
| CY2012Q3 | us-gaap |
Revenues
Revenues
|
3113000 | USD |
| cldx |
Revenue From Product Development And Licensing Agreements
RevenueFromProductDevelopmentAndLicensingAgreements
|
103000 | USD | |
| cldx |
Revenue From Contracts And Grants
RevenueFromContractsAndGrants
|
228000 | USD | |
| CY2013Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q4 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
5746000 | USD |
| CY2013Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
297000000 | shares |
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
254000 | USD |
| CY2012Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
17864000 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
33650000 | USD | |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
64359513 | shares |
| CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
500000 | USD |
| CY2013Q3 | cldx |
Operating Leases Number Of Renewal Options
OperatingLeasesNumberOfRenewalOptions
|
2 | item |
| cldx |
Operating Leases Period Of Renewal Options
OperatingLeasesPeriodOfRenewalOptions
|
P5Y | ||
| CY2013Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16795000 | USD |
| dei |
Entity Registrant Name
EntityRegistrantName
|
Celldex Therapeutics, Inc. | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000744218 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-09-30 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
| CY2013Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
81108234 | shares |
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24897000 | USD |
| CY2012Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
44000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1108000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
85114000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7205000 | USD |
| CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
424000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
125541000 | USD |
| CY2013Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q3 | us-gaap |
Assets Current
AssetsCurrent
|
139946000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
745000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
10960000 | USD |
| CY2012Q4 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
5592000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17685000 | USD |
| CY2013Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
3000000 | shares |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
29767000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
64000 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
357094000 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-264129000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
95774000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
125541000 | USD |
| CY2013Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| us-gaap |
Royalty Revenue
RoyaltyRevenue
|
7224000 | USD | |
| us-gaap |
Revenues
Revenues
|
7555000 | USD | |
| us-gaap |
Royalty Revenue
RoyaltyRevenue
|
2334000 | USD | |
| CY2012Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
11769000 | USD |
| CY2012Q3 | us-gaap |
Royalty Expense
RoyaltyExpense
|
3006000 | USD |
| CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14751000 | USD |
| CY2012Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
105000 | USD |
| CY2012Q3 | us-gaap |
Interest Expense
InterestExpense
|
381000 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-15027000 | USD |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.25 | |
| CY2012Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
59467000 | shares |
| us-gaap |
Royalty Expense
RoyaltyExpense
|
7224000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7372000 | USD | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
836000 | USD | |
| us-gaap |
Costs And Expenses
CostsAndExpenses
|
49082000 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-41527000 | USD | |
| us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
436000 | USD | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.75 | ||
| us-gaap |
Interest Expense
InterestExpense
|
1225000 | USD | |
| CY2012Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2835000 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
3000000 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
297000000 | shares |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
56090000 | shares | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-42316000 | USD | |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1000 | USD |
| CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
23187000 | USD |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
52000 | USD |
| CY2012Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14974000 | USD |
| us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2000 | USD | |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
121000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-42193000 | USD | |
| us-gaap |
Royalty Expense
RoyaltyExpense
|
2334000 | USD | |
| CY2013Q3 | us-gaap |
Revenues
Revenues
|
980000 | USD |
| CY2013Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
24249000 | USD |
| CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23269000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-59328000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-59547000 | USD | |
| CY2013Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-23002000 | USD |
| CY2013Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-23140000 | USD |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1576000 | USD | |
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
420000 | USD | |
| us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
6000 | USD | |
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
74000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1614000 | USD | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
169000 | USD | |
| us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-138000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
8000 | USD | |
| CY2013Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
80000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1495000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
620000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-36456000 | USD | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
45432000 | USD | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
57900000 | USD | |
| us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
218000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-12443000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
62872000 | USD | |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11899000 | USD |
| us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
41000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
60185000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
2000 | USD | |
| us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
11288000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
114187000 | USD | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
2931000 | USD | |
| CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14626000 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-10271000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-63601000 | USD | |
| dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
| cldx |
Revenue From Contracts And Grants
RevenueFromContractsAndGrants
|
1040000 | USD | |
| CY2013Q3 | cldx |
Available For Sale Securities Considered To Be Other Than Temporarily Impaired
AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired
|
0 | USD |
| CY2013Q3 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
121962000 | USD |
| us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
2646000 | USD | |
| us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
11029000 | USD | |
| us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
100000 | USD | |
| us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
200000 | USD | |
| CY2013Q3 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
890000 | USD |
| CY2013Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2468000 | USD |
| CY2013Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8814000 | USD |
| CY2013Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
157000 | USD |
| CY2013Q3 | us-gaap |
Assets
Assets
|
180955000 | USD |
| CY2013Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1982000 | USD |
| CY2013Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13807000 | USD |
| CY2013Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
81000 | USD |
| CY2013Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
477595000 | USD |
| CY2013Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-323617000 | USD |
| CY2013Q3 | cldx |
Revenue From Product Development And Licensing Agreements
RevenueFromProductDevelopmentAndLicensingAgreements
|
40000 | USD |
| CY2013Q3 | cldx |
Revenue From Contracts And Grants
RevenueFromContractsAndGrants
|
940000 | USD |
| cldx |
Revenue From Product Development And Licensing Agreements
RevenueFromProductDevelopmentAndLicensingAgreements
|
117000 | USD | |
| us-gaap |
Revenues
Revenues
|
3491000 | USD | |
| CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20417000 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
49597000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10128000 | USD | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
760000 | USD | |
| us-gaap |
Costs And Expenses
CostsAndExpenses
|
62819000 | USD | |
| CY2013Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
142000 | USD |
| CY2013Q3 | us-gaap |
Interest Expense
InterestExpense
|
13000 | USD |
| us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
682000 | USD | |
| us-gaap |
Interest Expense
InterestExpense
|
842000 | USD | |
| CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.29 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.76 | ||
| CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
81015000 | shares |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
78676000 | shares | |
| us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-3000 | USD | |
| CY2013Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
138000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-56000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1422000 | USD | |
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1232000 | USD | |
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
21000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3400000 | USD | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
97000 | USD | |
| us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
846000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1457000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-267000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2954000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1432000 | USD | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
30679000 | USD | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
92400000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1901000 | USD | |
| us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
21000 | USD | |
| us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
44000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
106045000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-3000 | USD | |
| CY2013Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
1237000 | USD |
| CY2013Q3 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
0 | USD |
| us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
0 | USD | |
| CY2013Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6086377 | shares |
| CY2012Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5360999 | shares |
